Skip to content

Effects of Exercise in Hemodialysis

Effects of an Intradialytic Aerobic Exercise Program on Echocardiographic Findings in Patients With End-Stage Chronic Kidney Disease on Hemodialysis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07507981
Enrollment
18
Registered
2026-04-02
Start date
2025-05-01
Completion date
2026-03-15
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Cronic Kidney Disease, Hemodialysis

Keywords

Intradialytic Exercise, Hemodialysis, End Stage Cronic Kidney Disease

Brief summary

Objective: To evaluate the effects of a six-month intradialytic aerobic exercise program on left ventricular ejection fraction in patients with end-stage kidney disease undergoing maintenance hemodialysis. Materials and Methods Design: Open-label, single-center, quasi-experimental, single-group study with pre- and post-intervention measurements. Study setting: the outpatient hemodialysis unit of the National Institute of Medical Sciences and Nutrition Salvador Zubirán. Participants: Patients aged ≥18 years with chronic kidney disease on hemodialysis for at least three months, who are at their dry weight. Procedures: An echocardiogram will be performed post-hemodialysis. Subsequently, patients will undergo a 30-minute intradialytic aerobic exercise program at submaximal intensity during the second hour of dialysis, three times per week for six months. At the end of the six-month period, a post-hemodialysis echocardiogram will be repeated.

Interventions

OTHERIntradialytic aerobic exercise program

A six-month intradialytic aerobic exercise program consisting of 30-minute sessions at submaximal intensity, performed during the second hour of hemodialysis three times per week.

Sponsors

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged ≥18 years * Receiving hemodialysis with a stable prescription for at least 3 months * At their prescribed dry weight * Provision of written informed consent

Exclusion criteria

* Active cardiovascular disease within the past 3 months * Left ventricular ejection fraction \<40% * Physical and/or cognitive impairment precluding exercise * Blood pressure \>160/110 mmHg

Design outcomes

Primary

MeasureTime frameDescription
Left ventricular ejection fractionFrom study enrollment to the initiation of the exercise program (within a maximum of 6 weeks), and subsequently from completion of the exercise program to up to 6 weeks thereafterLeft ventricular ejection fraction measured by transthoracic echocardiogram

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026